CAR-T (Allogeneic)
Memory NK (Allogeneic)
-- Researchers Shared Findings Including a Clinically Manageable Safety Profile and Anti-leukemic Activity with WU-CART-007 in Patients with R/R T-ALL/LBL…
-- Researchers to Present New Phase 2 Data Showing Safety and Anti-Leukemic Activity with WU-CART-007 and Additional New Findings for…
The Woodlands, TX, and St. Louis, MO, March 14, 2024/ Cision / - Cellipont Bioservices, a leading cell therapy Contract…
Wugen is a clinical-stage biotechnology company
Cellular therapies originating from healthy donors
Come join our growing teams in San Diego and St. Louis